FDA OKs Gleolan, First Fluorescing Agent for Glioma Surgery FDA OKs Gleolan, First Fluorescing Agent for Glioma Surgery
Gleolan oral solution (aminolevulinic acid hydrochloride) enhances the visualization of malignant tissue during glioma surgery.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news
FDA Approves Gleolan (aminolevulinic acid hydrochloride) as an Optical Imaging Agent in Patients with Gliomas
June 6, 2017 - The U.S. Food and Drug Administration (FDA) has approved Gleolan [aminolevulinic acid hydrochloride (ALA HCl)] as an optical imaging agent indicated in patients with gliomas (suspected World Health Organization Grades III or IV on... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 6, 2017 Category: Drugs & Pharmacology Source Type: news
New target found to attack an incurable brain tumor in children
(Ann& Robert H. Lurie Children's Hospital of Chicago) Research shows that a tumor suppressor gene p16 is turned off by a histone mutation (H3.3K27M), which is found in up to 70 percent of childhood brain tumors called diffuse intrinsic pontine glioma (DIPG). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 6, 2017 Category: International Medicine & Public Health Source Type: news
Texas girl died five days after brain cancer diagnosis
Jade Bridier, from Bryan, Texas, was diagnosed with a rare brain tumor, called diffuse intrinsic pontine glioma (DIPG) in August. She died just five days after her diagnosis at four years old. (Source: the Mail online | Health)
Source: the Mail online | Health - May 30, 2017 Category: Consumer Health News Source Type: news
Northwestern Medicine initiates Phase I trial of stem cells + cold virus for glioma
US-based advanced healthcare solutions provider Northwestern Medicine has initiated the Phase I trial of a new neural stem-cell therapy in combination with a common cold virus to detect and destroy brain cancer in patients with malignant glioma. (Source: Drug Development Technology)
Source: Drug Development Technology - May 24, 2017 Category: Pharmaceuticals Source Type: news
